Each vial contains
Paclitaxel (albumin bound) …… 100 mg
Description
Paclitaxel for Injection (Albumin Bound) is an injectable nanoparticle formulation composed of paclitaxel bound to human serum albumin.
It acts by stabilizing microtubules and inhibiting mitosis, thereby exerting potent antitumor activity. The albumin-bound form improves tumor targeting, reduces solvent-related toxicity, and generally does not require routine premedication for hypersensitivity.
Indications
Metastatic breast cancer
Advanced non-small cell lung cancer
Metastatic adenocarcinoma of the pancreas
Other malignant tumors as clinically prescribed
Storage
Store at 2‑8°C.
Protect from light.
Do not freeze.
Keep out of reach of children.
Warning
For intravenous infusion only.
Contraindicated in patients with hypersensitivity to paclitaxel, human albumin, or any excipients.
Contraindicated in patients with severe neutropenia.
Use with caution in hepatic impairment, elderly patients, and those with cardiovascular disease.
Monitor complete blood count, liver function, and neuropathy during treatment.
May cause myelosuppression, peripheral neuropathy, fatigue, musculoskeletal pain, nausea, and alopecia.
Must be administered under the supervision of a qualified oncologist.
